In addition to patents issued in the United States, international patents have been filed in Canada, Australia, the European Union, and India. International patent protection in these countries expands AIM’s global footprint and ensures AIM’s utilization and growth in the international healthcare sector.
The global minimally invasive market is expected to grow by 9.1% to $90.4B (CAGR) in 2027. The market for anesthesia monitoring devices is projected to grow at a rate of 10.2% from $1.74B to $3.39B within the next few years.